https://www.nobadreps.com/recovery-and-mobility/ipc-2026-para-sport-medical-coverage-standards-update No Bad Reps en 2026-06-09T13:51:24.509Z IPC updates 2026 para-sport medical coverage standards International Paralympic Committee, IPC, Para-sport, Medical Staffing, Athlete Safety /api/media/articles/nobadreps/nobadreps-ipc-2026-para-sport-medical-coverage-standards-update-1781013055469/hero.png Para-athlete receiving urgent medical care from a specialized team on a sports field, highlighting improved safety standards. https://www.nobadreps.com/nutrition-science/sports-pharmacy-training-gaps-athlete-healthcare No Bad Reps en 2026-06-09T13:49:24.013Z Sports pharmacy training gaps hinder athlete healthcare integration sports pharmacy, pharmacy students, athlete healthcare, inadvertent doping, adverse drug events https://www.nobadreps.com/hypertrophy-hub/youth-football-growth-maturity-monitoring No Bad Reps en 2026-06-09T13:48:06.461Z Why youth football needs growth and maturity monitoring youth football, growth monitoring, maturity monitoring, biological age, chronological age /api/media/articles/nobadreps/nobadreps-youth-football-growth-maturity-monitoring-1781012852752/hero.png Young football players undergoing performance monitoring in a modern training facility, guided by scientific data and coaching. https://www.nobadreps.com/nutrition-science/plant-based-protein-market-us-retail-lag No Bad Reps en 2026-06-08T18:53:28.683Z Plant-Based Protein Market Soars, But U.S. Retail Lags Behind Innovations plant-based protein market, US retail sales, food industry trends, consumer behavior, market growth /api/media/articles/nobadreps/nobadreps-plant-based-protein-market-us-retail-lag-1780944778798/hero.png A futuristic grocery store aisle showcasing innovative plant-based protein products, with a contrasting visual of lagging sales data in the background. https://www.nobadreps.com/hypertrophy-hub/survodutide-drug-slashes-visceral-liver-fat No Bad Reps en 2026-06-08T06:45:43.458Z Survodutide drug slashes visceral and liver fat in trials Survodutide, obesity drug, visceral fat, liver fat, fat reduction /api/media/articles/nobadreps/nobadreps-survodutide-drug-slashes-visceral-liver-fat-1780901109407/hero.png Microscopic view of Survodutide drug molecules precisely targeting and reducing visceral and liver fat cells within the human body.